Zdrowie i gospodarka · 29/11/2012
FDA Requests Public Comment on Proposed Collection of Information for Constituent Materials in Licensed Biological Products
The Food and Drug Administration (FDA) is seeking public input on a proposed rule that would require the use of constituent materials in licensed biological products, as mandated by the Paperwork Reduction Act of 1995
Source: Federal Register — Food and Drug AdministrationOpen original release →